NCT04768257Completed
Physical Activity Post COVID-19
Physical Activity Post Coronavirus (COVID-19). a Longitudinal Study
Source: ClinicalTrials.gov · Last updated 24 Feb 2025
Brief summary (registry, in English)
THis study aims to examine PA trajectory, and potential behaviour-change factors least 12 months after COVID-19, across different levels of acute disease severity, and specifically in people with and without Long COVID.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 148 (actual)
- First submitted
- 21 Feb 2021
- Start date
- May 2021
- Primary completion date
- Dec 2023
- Lead sponsor
- University of Alcala
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT04768257
What you commit to
- Study type: Observational
- Participants enrolled: 148
- From May 2021 to the primary completion date, Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of signs of cognitive impairment or significant cardiovascular, neurological, and/or musculoskeletal disease, which may prevent the assessment tests and therefore limit participation. In particular, reasons for exclusion will be the following: cognitive disorders, such as sequelae of Alzheimer's disease, senile dementia; comprehension disorders, such as Wernicke's aphasia; cognitive-motor disorders, such as hemiparesis/hemiplegia due to stroke; musculoskeletal disorders, such as unconsolidated fractures, external prostheses (including replacements in amputees); cardiovascular disorders, such as unstable angina, recent acute myocardial infarction, among others.
- Vacination before infection.
Other
- Reinfections during follow-up.
Who the study is looking for
- At least, 18 years of age;
- Diagnosis with COVID-19;
- Stable condition at hospital discharge or after 21 days of being treated at home (needed time to recover from an acute respiratory infection; however, patients treated at home should report a negative result in polymerase chain reaction \[PCR\] test).
- Those reporting clinically relevant symptoms among dyspnoea, fatigue, anxiety, depression or impaired health-related quality of life will be considered affected from post-COVID-19 condition or Long COVID.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital of Guadalajara Coordinator of this site? Confirm its status | Guadalajara | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.